Abstract
In December, the Substance Abuse and Mental Health Services Administration (SAMHSA) released a notice of proposed rulemaking (NPRM) that would make permanent the take‐home exemptions for methadone under which, due to COVID‐19, it was possible for “less stable” patients to receive more take‐homes (https://onlinelibrary.wiley.com/doi/10.1002/adaw.33643). In addition, the proposal would remove the one‐year requirement for opioid use disorder (OUD), remove the reliance on toxicology tests and the length of time in treatment, and allow telehealth inductions by methadone.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
